A Deep Learning-informed Interpretation of Why and when Dose Metrics Outside the PTV Can Affect the Risk of Distant Metastasis in SBRT NSCLC Patients

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2024 Sep 28

PMID 39334387

Authors

D Dudas

T J Dilling

I El Naqa

Affiliations

Soon will be listed here.

Abstract

Purpose: Recent papers suggested a correlation between the risk of distant metastasis (DM) and dose outside the PTV, though conclusions in different publications conflicted. This study resolves these conflicts and provides a compelling explanation of prognostic factors.

Materials And Methods: A dataset of 478 NSCLC patients treated with SBRT (IMRT or VMAT) was analyzed. We developed a deep learning model for DM prediction and explainable AI was used to identify the most significant prognostic factors. Subsequently, the prognostic power of the extracted features and clinical details were analyzed using conventional statistical methods.

Results: Treatment technique, tumor features, and dosiomic features in a 3 cm wide ring around the PTV (PTV) were identified as the strongest predictors of DM. The Hazard Ratio (HR) for D was significantly above 1 (p < 0.001). There was no significance of the PTV dose after treatment technique stratification. However, the dose in PTV was found to be a highly significant DM predictor (HR > 1, p = 0.004) when analyzing only VMAT patients with small and spherical tumors (i.e., sphericity > 0.5).

Conclusions: The main reason for conflicting conclusions in previous papers was inconsistent datasets and insufficient consideration of confounding variables. No causal correlation between the risk of DM and dose outside the PTV was found. However, the mean dose to PTV can be a significant predictor of DM in small spherical targets treated with VMAT, which might clinically imply considering larger PTV margins for smaller, more spherical tumors (e.g., if IGTV > 2 cm, then margin ≤ 7 mm, else margin > 7 mm).

References

Xu Y, Deng W, Yang S, Li P, Kong Y, Tian Y . Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer. Sci Rep. 2017; 7(1):14863. PMC: 5665865. DOI: 10.1038/s41598-017-14629-w. View

Narayanasamy G, Desai D, Maraboyina S, Penagaricano J, Zwicker R, Johnson E . A Dose Falloff Gradient Study in RapidArc Planning of Lung Stereotactic Body Radiation Therapy. J Med Phys. 2018; 43(3):147-154. PMC: 6172857. DOI: 10.4103/jmp.JMP_38_18. View

Talebi A, Celis-Morales C, Borumandnia N, Abbasi S, Pourhoseingholi M, Akbari A . Predicting metastasis in gastric cancer patients: machine learning-based approaches. Sci Rep. 2023; 13(1):4163. PMC: 10011363. DOI: 10.1038/s41598-023-31272-w. View

Fried D, Tucker S, Zhou S, Liao Z, Mawlawi O, Ibbott G . Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014; 90(4):834-42. PMC: 4349397. DOI: 10.1016/j.ijrobp.2014.07.020. View

Kim S, Myong J, Suh H, Lee K, Youn Y . Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer. PLoS One. 2015; 10(6):e0130848. PMC: 4477980. DOI: 10.1371/journal.pone.0130848. View

Borm K, Oechsner M, Wiegandt M, Hofmeister A, Combs S, Duma M . Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data. BMC Cancer. 2018; 18(1):760. PMC: 6056919. DOI: 10.1186/s12885-018-4647-4. View

Diamant A, Chatterjee A, Faria S, El Naqa I, Bahig H, Filion E . Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)?. Radiother Oncol. 2018; 128(3):513-519. DOI: 10.1016/j.radonc.2018.05.012. View

Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N . The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021; 157:308-347. PMC: 8568058. DOI: 10.1016/j.ejca.2021.07.039. View

Stambaugh C, Nelms B, Dilling T, Stevens C, Latifi K, Zhang G . Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments. Med Phys. 2013; 40(9):091710. DOI: 10.1118/1.4818255. View

10.

Diamant A, Heng V, Chatterjee A, Faria S, Bahig H, Filion E . Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT. Radiother Oncol. 2020; 144:201-208. DOI: 10.1016/j.radonc.2020.01.017. View

11.

Gao H, He Z, Du X, Wang Z, Xiang L . Machine Learning for the Prediction of Synchronous Organ-Specific Metastasis in Patients With Lung Cancer. Front Oncol. 2022; 12:817372. PMC: 9136456. DOI: 10.3389/fonc.2022.817372. View

12.

Zhou H, Dong D, Chen B, Fang M, Cheng Y, Gan Y . Diagnosis of Distant Metastasis of Lung Cancer: Based on Clinical and Radiomic Features. Transl Oncol. 2017; 11(1):31-36. PMC: 5697996. DOI: 10.1016/j.tranon.2017.10.010. View

13.

Wu J, Gensheimer M, Zhang N, Han F, Liang R, Qian Y . Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2019; 104(4):942-952. PMC: 6579673. DOI: 10.1016/j.ijrobp.2019.03.036. View

14.

Dudas D, Saghand P, Dilling T, Perez B, Rosenberg S, El Naqa I . Deep Learning-Guided Dosimetry for Mitigating Local Failure of Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023; 119(3):990-1000. DOI: 10.1016/j.ijrobp.2023.11.059. View

15.

Jensen M, Abdellatif A, Chen J, Wong E . Study of the IMRT interplay effect using a 4DCT Monte Carlo dose calculation. Phys Med Biol. 2012; 57(8):N89-99. DOI: 10.1088/0031-9155/57/8/N89. View

16.

Lalonde R, Abdelhakiem M, Keller A, Huq M . Response to "Letter to the editor of radiotherapy and oncology regarding of the article "Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer" by Lalonde.... Radiother Oncol. 2022; 177:242. DOI: 10.1016/j.radonc.2022.05.032. View

17.

Leste J, Medjahed I, Arnaud F, Ferrand R, Franceries X, Bardies M . A study of the interplay effect for VMAT SBRT using a four-axes motion phantom. J Appl Clin Med Phys. 2020; 21(8):208-215. PMC: 7484847. DOI: 10.1002/acm2.12947. View

18.

Gensheimer M, Narasimhan B . A scalable discrete-time survival model for neural networks. PeerJ. 2019; 7:e6257. PMC: 6348952. DOI: 10.7717/peerj.6257. View

19.

Collins G, Reitsma J, Altman D, Moons K . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015; 13:1. PMC: 4284921. DOI: 10.1186/s12916-014-0241-z. View

20.

Lalonde R, Abdelhakiem M, Keller A, Huq M . Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer. Radiother Oncol. 2022; 169:90-95. DOI: 10.1016/j.radonc.2022.02.019. View